RS50693B - Stabilni farmaceutski gel diklofenak natrijuma - Google Patents

Stabilni farmaceutski gel diklofenak natrijuma

Info

Publication number
RS50693B
RS50693B RSP-2008/0570A RSP20080570A RS50693B RS 50693 B RS50693 B RS 50693B RS P20080570 A RSP20080570 A RS P20080570A RS 50693 B RS50693 B RS 50693B
Authority
RS
Serbia
Prior art keywords
diclofenac sodium
stable pharmaceutical
gel
pharmaceutical gel
pharmaceutical use
Prior art date
Application number
RSP-2008/0570A
Other languages
English (en)
Inventor
Ioulia Tseti
Original Assignee
Uni-Pharma Kleon Tsetis Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uni-Pharma Kleon Tsetis Pharmaceutical filed Critical Uni-Pharma Kleon Tsetis Pharmaceutical
Publication of RS50693B publication Critical patent/RS50693B/sr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

Polučvrsta gel formulacija sa diklofenak Na, kao aktivnom supstancom, namenjena je farmacetskoj upotrebi, u kojoj je gel smeša pogodna za površinsku, lokalnu primenu diklofenak natrij uma, preko kože, pri čemu navedeni gel sadrži diklofenak natrij um i sve farmaceutski prihvatljive ekscipijente: propilen glikol, metocel E4 MP, metil-p-hidrosibenzoat, metil salicilat, mentol i prečišćenu vodu za farmaceutsku upotrebu. Prijava sadrži još 8 patentnih zahteva.
RSP-2008/0570A 2005-06-14 2005-06-14 Stabilni farmaceutski gel diklofenak natrijuma RS50693B (sr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/GR2005/000023 WO2006134406A1 (en) 2005-06-14 2005-06-14 Stable pharmaceutical gel of diclofenac sodium

Publications (1)

Publication Number Publication Date
RS50693B true RS50693B (sr) 2010-06-30

Family

ID=35788029

Family Applications (1)

Application Number Title Priority Date Filing Date
RSP-2008/0570A RS50693B (sr) 2005-06-14 2005-06-14 Stabilni farmaceutski gel diklofenak natrijuma

Country Status (4)

Country Link
EP (1) EP1890687B1 (sr)
CY (1) CY1108785T1 (sr)
RS (1) RS50693B (sr)
WO (1) WO2006134406A1 (sr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2143421A1 (en) 2008-07-07 2010-01-13 Almirall Hermal GmbH Topical composition for the treatment of actinic keratosis
DE202010012255U1 (de) * 2010-09-07 2010-11-18 Krewel Meuselbach Gmbh Nasenspray
US9468618B2 (en) * 2014-12-12 2016-10-18 Lupin Atlantis Holdings Sa Topical pharmaceutical gel composition of diclofenac sodium
US9468617B2 (en) * 2014-12-12 2016-10-18 Lupin Atlantis Holdings Sa Topical pharmaceutical gel composition of diclofenac sodium
US9687549B2 (en) * 2015-03-14 2017-06-27 Lupin Atlantis Holdings Sa Topical pharmaceutical gel composition of diclofenac sodium

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4670254A (en) * 1983-12-09 1987-06-02 Toko Yakuhin Industry Co., Ltd. Gel preparations for topical application of diclofenac sodium
EP0450123B1 (de) * 1990-04-05 1995-07-05 Knoll AG Diclofenac-Natrium enthaltende pharmazeutische Zusammensetzung zur topischen Anwendung
JP3086290B2 (ja) * 1991-07-26 2000-09-11 エスエス製薬株式会社 ジクロフェナクナトリウム貼付剤
GB9902227D0 (en) * 1999-02-01 1999-03-24 Cipla Limited Pharmaceutical composition for topical administration
OA12613A (en) * 2001-05-31 2006-06-09 Pharmacia Corp Skin-permeable composition comprising a selective cyclooxygenase-2 inhibitor a monohydric alcohol.
WO2005027977A2 (en) * 2003-09-22 2005-03-31 Agis Industries (1983) Ltd. Diclofenac compositions for the treatment of skin disorders

Also Published As

Publication number Publication date
EP1890687A1 (en) 2008-02-27
WO2006134406A1 (en) 2006-12-21
EP1890687B1 (en) 2008-09-17
CY1108785T1 (el) 2014-04-09

Similar Documents

Publication Publication Date Title
ES2553742T3 (es) Forma de dosificación farmacéutica que comprende 6'-fluor-(N-metil- o N,N-dimetil)-4-fenil-4',9'-dihidro-3'H-espiro[ciclohexano-1,1'-pirano[3,4,b]indol]-4-amina
AR124134A2 (es) Formulación de uso tópico para un inhibidor de jak
CL2013003163A1 (es) Composición transdermica de ibuprofeno, util en el tratamiento del dolor o la inflamacion.
BRPI0414907A (pt) formulações farmacêuticas com liberação sustentada injetáveis, orais ou tópicas
AR048705A1 (es) Composiciones farmaceuticas para el tratamiento de los trastornos sexuales ii
AR037592A1 (es) Formulaciones farmaceuticas de 5,7,14-triazatetraciclo (10.3.1.02,11.04,9)-hexadeca-2(11),3,5,7,9-pentaeno
JP2013515002A5 (sr)
BRPI0508933A (pt) composições para entrega tópica
UY31294A1 (es) Derivados de tetrahidrocarbozol, métodos para obtenerlos, formulaciones que los contienen y usos de los mismos
AR069572A1 (es) Formulaciones farmaceuticas de fenilefrina y composiciones para absorcion transmucosal
AR039164A1 (es) Sales de venlafaxina de baja solubilidad en agua
AR061166A1 (es) Composiciones farmaceuticas para la liberacion sostenida de fenilferina
BR0311414A (pt) Agente terapêutico para uma bexiga hiperativa
CL2008002466A1 (es) Composicion farmaceutica topica anhidra que comprende un vasodilatador y un vehiculo aceptable; uso de la composicion anhidra topica en las areas genitales para obtener bienestar sexual mejorado.
AR062112A1 (es) Derivados ciclicos como moduladores de la actividad del receptor de quimiocina
AR065582A1 (es) Mejoras en composiciones medicinales o relativas a las mismas
AR054987A1 (es) Composicion veterinaria trasmucosal
WO2004100893A3 (en) Methods for treatment of inflammatory diseases using ct-3 or analogs thereof
RS50693B (sr) Stabilni farmaceutski gel diklofenak natrijuma
AR066666A1 (es) Composicion farmaceutica que comprende la combinacion de un agente antiinflamatorio no esteroideo y un agente anticonvulsivante
AR045912A1 (es) Composiciones farmaceuticas que contienen derivados de azetidina
AR036755A1 (es) Una composicion en forma de gel transparente para la administracion de diclofenac sodico a traves de la piel
BR0108313A (pt) Composição farmacêutica para injeção intramuscular contendo loxoprofeno
AR040515A1 (es) Formula farmaceutica topica estabilizada con contenido de ketoprofeno
RU2005132004A (ru) Стабилизированные композиции для местного применения, содержащие кетопрофен